GP Act Return On Equity Over Time
| GPAT Stock | 10.08 0.01 0.1% |
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out GP Act Performance and GP Act Correlation. GPAT |
Is Diversified Financial Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of GP Act. If investors know GPAT will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about GP Act listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share 0.15 |
The market value of GP Act III is measured differently than its book value, which is the value of GPAT that is recorded on the company's balance sheet. Investors also form their own opinion of GP Act's value that differs from its market value or its book value, called intrinsic value, which is GP Act's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because GP Act's market value can be influenced by many factors that don't directly affect GP Act's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between GP Act's value and its price as these two are different measures arrived at by different means. Investors typically determine if GP Act is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, GP Act's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Cross Equities Return On Equity Analysis
Compare GP Act III and related stocks such as Hudson Pacific Properties, Luxfer Holdings PLC, and Codexis Return On Equity Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| HPP | (0.0358) | (0.0167) | (0.0059) | (0.0023) | 0.0198 | (0.012) | 0.0111 | 0.019 | 0.028 | (0.0183) | (0.0342) | (0.0306) | (0.0504) | (0.0565) | (0.0537) |
| LXFR | 0.3957 | 0.6698 | 0.2849 | 0.1779 | 0.1665 | 0.0949 | 0.1543 | 0.0709 | 0.1356 | 0.0138 | 0.1197 | 0.143 | 0.1298 | (0.0089) | (0.0085) |
| CDXS | 0.3538 | (0.1612) | (0.3934) | (0.9957) | (0.7248) | (0.3314) | (0.4481) | (0.9368) | (0.1932) | (0.1131) | (0.1411) | (0.1294) | (0.232) | (0.8802) | (0.84) |
| BAK | 0.0649 | (0.0539) | (0.0854) | 0.0676 | 0.1431 | 1.9261 | (0.1502) | 0.6481 | 0.4223 | (0.5405) | 3.1854 | 1.7779 | (0.112) | (1.147) | (1.09) |
| LGIH | 0.2579 | 0.2579 | 0.385 | 0.1358 | 0.1546 | 0.2136 | 0.2112 | 0.2313 | 0.2367 | 0.2113 | 0.2844 | 0.3078 | 0.1988 | 0.1073 | 0.1 |
| NL | 0.0383 | 0.1968 | 0.1989 | (0.1556) | 0.1202 | (0.1594) | 0.086 | 0.3462 | (0.1443) | 0.0847 | 0.0471 | 0.1412 | 0.0886 | (0.0062) | (0.0059) |
| FSP | (0.0177) | 0.0472 | 0.0088 | 0.0189 | 0.0134 | 0.0374 | 0.0087 | (0.0183) | 0.0156 | 0.0082 | 0.0425 | 0.1184 | 0.0014 | (0.0675) | (0.0641) |
GP Act III and related stocks such as Hudson Pacific Properties, Luxfer Holdings PLC, and Codexis Return On Equity description
Return on Equity is the amount of GP Act III net income returned as a percentage of GP Act equity. Return on equity measures GP Act profitability by revealing how much profit GP Act III Acquisition generates with the money shareholders have invested. A measure of the profitability of a business in relation to the equity, calculated by dividing net income by shareholder's equity.My Equities
My Current Equities and Potential Positions
| GP Act III Acquisition | GPAT |
Specialization | Financial Services, Financial Services |
| Location | Cayman Islands |
| Exchange | NASDAQ Exchange |
null 10.08
Additional Tools for GPAT Stock Analysis
When running GP Act's price analysis, check to measure GP Act's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy GP Act is operating at the current time. Most of GP Act's value examination focuses on studying past and present price action to predict the probability of GP Act's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move GP Act's price. Additionally, you may evaluate how the addition of GP Act to your portfolios can decrease your overall portfolio volatility.